Register Forgot My Password
Effect of Cardiac Resynchronization Therapy in Patients Without Left Ventricular Dyssynchrony
Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation: Results From a Multicenter Prospective Registry
Ablation of Atrial Fibrillation Under Therapeutic Warfarin Reduces Periprocedural Complications: Evidence From a Meta-Analysis
Evaluation of Risk Stratification Schemes for Ischaemic Stroke and Bleeding in 182,678 Patients With Atrial Fibrillation: The Swedish Atrial Fibrillation Cohort Study
2011 Focused Updates Incorporated Into the 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2008 Clinical Performance Measures for Adults With Nonvalvular Atrial Fibrillation or Atrial Flutter
2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
Afib Risk, FAME II, and Lifetime Risk of CV Disease
FDA Approves Rivaroxaban
Atrial Functional Mitral Regurgitation
BiV Pacing for Bradycardia and Preserved LVEF
Colchicine for the Prevention of the Post-Pericardiotomy Syndrome Atrial Fibrillation Substudy (COPPS POAF)
Implantable Cardioverter Defibrillator Interventions or Death (ALPHEE)
Atrial Fibrillation catheter Ablation versus Surgical Ablation Treatment (FAST)
The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF)
ACTION Registry-GWTG Results: July 1, 2009 – June 30, 2010
Quantitative Tissue Characterization of Infarct Core and Border Zone in Patients With Ischemic Cardiomyopathy by Magnetic Resonance Is Associated With Future Cardiovascular Events